Manufacturing · Illinois, United States · 60,000 Employees
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs anddrug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield.Read More
View Company Info for Free
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Popular SearchesBaxter International IncBaxter Healthcare CorpBaxter InternationalBaxter HealthcareBaxterSIC Code 38,384NAICS Code 33,339Ticker NYSE: BAXShow More
1
2
3
4
5
6
Phone
EmailBaxter uses at least 5 email formats with first_last (ex. John_Smith@baxter.com) being used 66.3% of the time
| Baxter Email Formats | Percentage | |
|---|---|---|
| first_last | John_Smith@baxter.com | 66.3% |
| first.last | John.Smith@baxter.com | 6.9% |
| first initials + last | JSmith@baxter.com | 5.9% |
| first + last | JohnSmith@baxter.com | |
| first | John@baxter.com | |
Get Verified Emails
Jul 18, 2022
TRUMPF
Jul 18, 2022
Werner Trumpf
Jul 18, 2022
QUINTON CARDIOLOGY
Jul 18, 2022
Burdick
Nov 17, 2021
Connecta Soft, SA de CV
Nov 01, 2017
EHT Werkzeugmaschinen
See More Acquisitions & Subsidiaries
Dec 3, 2023
Nov 28, 2023Nov 22, 2023Nov 14, 2023
Nov 6, 2023Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV n... Read More
Sign Up for Free
Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Supercharge Your Prospecting
Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Grow Your Business
Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.
